Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this open, multicenter phase II trial is to confirm the tolerance and evaluate the efficacy of the SclerFIX product, an allograft of umbilical cord lining membrane, in reinforcement of scleral thinning in patients who underwent eye tumor exeresis.
Full description
As scleral graft is forbidden in France, it cannot be used to reinforce the sclera. This study investigational product, SclerFIX, was developed to substitute scleral grafts.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
17 participants in 1 patient group
Loading...
Central trial contact
Justine BOSC, MSc; Laurence BARNOUIN, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal